KATINA JONES: Open Payments
NPI 1972193563 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 17 payments from 6 companies in 2025. Trend: 2023 $171 · 2024 $113 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 7 | $160 |
| Janssen Pharmaceuticals, Inc | 4 | $78 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Alkermes, Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
Products named: INGREZZA, INVEGA SUSTENNA, COBENFY, UZEDY, ARISTADA, REXULTI.
Industry payments across LA — which companies pay providers there.
